EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Beta Bionics, Inc. (BBNX) had EBIT Margin of -105.69% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$17.64M |
|
$-28.66M |
|
$8.67M |
|
$8.97M |
|
$36.28M |
|
$-18.64M |
|
$-10.01M |
|
$-28.66M |
|
$-28.66M |
|
$-28.66M |
|
$-28.66M |
|
$-28.66M |
|
$-28.66M |
|
$-18.64M |
|
$-18.04M |
|
30.71M |
|
30.71M |
|
$-0.93 |
|
$-0.93 |
|
| Balance Sheet Financials | |
$261.92M |
|
$5.51M |
|
$76.11M |
|
$338.02M |
|
$16.49M |
|
-- |
|
$7.78M |
|
$24.27M |
|
$313.75M |
|
$313.75M |
|
$313.75M |
|
43.35M |
|
| Cash Flow Statement Financials | |
$-19.98M |
|
$-179.12M |
|
$211.12M |
|
$30.53M |
|
$42.55M |
|
$12.02M |
|
$2.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
50.86% |
|
-105.69% |
|
|
EBIT Margin |
-105.69% |
-- |
|
-162.46% |
|
-162.46% |
|
$-20.31M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.55 |
|
1.95 |
|
46.23 |
|
-9.13% |
|
-9.13% |
|
-8.48% |
|
-9.13% |
|
$7.24 |
|
$-0.66 |
|
$-0.65 |
|